Buying Tesla Stock? Wait Until You See This...
With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day.
Click Here...
pixel

APLS Insider Trading (Apellis Pharmaceuticals)

Insider Ownership Percentage: 9.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,256,582.88

Apellis Pharmaceuticals Insider Trading History Chart

Apellis Pharmaceuticals Share Price & Price History

$41.56
▲ +0.01 (0.02%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Finance PhD: Move Your Money Before April 30th
The clock just starting ticking on the biggest financial event in 20 years. The next few weeks could decide your wealth in 2021.
See what you should do now

Apellis Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2021Federico GrossiInsiderSell600$43.41$26,046.0056,714  
3/15/2021Alec MachielsDirectorSell2,500$46.77$116,925.00672,044  
3/15/2021Federico GrossiInsiderSell500$46.77$23,385.0057,314  
3/10/2021Pascal DeschateletsInsiderSell6,250$50.74$317,125.00
3/5/2021Federico GrossiInsiderSell5,000$48.62$243,100.0062,814  
2/9/2021Nicole D PerryVPSell2,000$50.00$100,000.004,500  
1/15/2021Alec MachielsDirectorSell2,500$53.15$132,875.00672,044  
1/14/2021Federico GrossiInsiderSell4,000$51.99$207,960.0035,827  
12/15/2020Cedric FrancoisCEOSell5,000$52.16$260,800.001,113,079  
12/14/2020A. Sinclair DunlopDirectorSell25,000$54.67$1,366,750.00672,044  
12/14/2020David O WatsonGeneral CounselSell18,333$50.94$933,883.02
12/7/2020A. Sinclair DunlopDirectorSell25,000$50.59$1,264,750.00  
12/4/2020A. Sinclair DunlopDirectorSell6,436$50.26$323,473.36  
12/4/2020Nicole D PerryVPSell18,000$50.00$900,000.0018,000  
12/1/2020Federico GrossiInsiderSell600$48.25$28,950.00  
11/16/2020Alec MachielsDirectorSell2,500$39.38$98,450.00672,044  
11/16/2020Cedric FrancoisCEOSell5,000$39.38$196,900.001,078,079  
11/2/2020Federico GrossiInsiderSell600$31.09$18,654.0027,725  
10/15/2020Alec MachielsDirectorSell2,500$35.00$87,500.00672,044  
10/15/2020Cedric FrancoisCEOSell5,000$34.46$172,300.001,083,079  
10/7/2020Alec MachielsDirectorSell7,500$35.00$262,500.00677,044  
10/7/2020Victoria L. BrownInsiderSell12,000$35.00$420,000.00  
9/15/2020Cedric FrancoisCEOSell5,000$30.96$154,800.00
9/1/2020Federico GrossiInsiderSell600$31.58$18,948.0028,925  
8/20/2020Cedric FrancoisCEOSell3,457$30.00$103,710.001,093,079  
8/18/2020Cedric FrancoisCEOSell1,543$30.00$46,290.001,096,536  
8/3/2020Federico GrossiInsiderSell600$26.28$15,768.0029,525  
7/15/2020Cedric FrancoisCEOSell5,000$32.12$160,600.001,098,079  
7/1/2020Federico GrossiInsiderSell850$32.43$27,565.5030,125  
6/15/2020Alec MachielsDirectorSell2,500$30.21$75,525.00
6/15/2020Cedric FrancoisCEOSell5,000$30.21$151,050.00
11/15/2019Cedric FrancoisCEOSell5,000$27.82$139,100.00
10/15/2019Cedric FrancoisCEOSell5,000$27.81$139,050.00
9/24/2019Pascal DeschateletsCOOSell42,460$24.82$1,053,857.20
9/16/2019Cedric FrancoisCEOSell5,000$26.59$132,950.00
8/29/2019Timothy Eugene SullivanCFOBuy11,699$29.71$347,577.2911,699  
8/15/2019Cedric FrancoisCEOSell10,000$26.80$268,000.00  
3/11/2019Morningside Venture InvestmentMajor ShareholderBuy441,176$17.00$7,499,992.00  
9/21/2018Morningside Venture InvestmentMajor ShareholderBuy81,323$19.48$1,584,172.04  
9/19/2018Morningside Venture InvestmentMajor ShareholderBuy140,000$18.34$2,567,600.00  
9/14/2018David O WatsonGeneral CounselSell15,776$18.78$296,273.28  
5/24/2018Lukas ScheiblerInsiderBuy2,935$20.37$59,785.95  
See Full Table

SEC Filings (Institutional Ownership Changes) for Apellis Pharmaceuticals (NASDAQ:APLS)

81.20% of Apellis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Apellis Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/5/2021Pacer Advisors Inc.1,669$72K0.0%-37.1%0.002%
3/12/2021DekaBank Deutsche Girozentrale50,700$2.77M0.0%-18.5%0.063%
3/8/2021Teachers Retirement System of The State of Kentucky105,144$6.01M0.1%+8.3%0.131%
3/2/2021Norges Bank662,697$37.91M0.0%N/A0.875%
3/1/2021UBS Asset Management Americas Inc.64,947$3.72M0.0%-2.9%0.086%
2/23/2021Principal Financial Group Inc.30,824$1.76M0.0%+23.3%0.041%
2/23/2021CWA Asset Management Group LLC4,000$0.23M0.0%N/A0.005%
2/18/2021Ghost Tree Capital LLC325,000$18.59M3.8%N/A0.429%
2/18/2021Truist Financial Corp4,320$0.25M0.0%N/A0.006%
2/17/2021Voloridge Investment Management LLC7,901$0.45M0.0%N/A0.010%
2/16/2021venBio Partners LLC490,471$28.06M2.5%-2.2%0.648%
2/16/2021Tri Locum Partners LP121,409$6.95M2.5%N/A0.160%
2/16/2021Morgan Stanley100,345$5.74M0.0%+152.1%0.132%
2/16/2021Tudor Investment Corp Et Al29,448$1.68M0.0%+47.7%0.039%
2/16/2021Nuveen Asset Management LLC268,416$15.35M0.0%-1.5%0.354%
2/16/2021Price T Rowe Associates Inc. MD3,045,329$174.19M0.0%+2.2%4.021%
2/16/2021Clough Capital Partners L P232,449$13.30M0.9%-42.7%0.307%
2/16/2021Engineers Gate Manager LP9,290$0.53M0.0%N/A0.012%
2/16/2021Avidity Partners Management LP774,000$44.27M1.4%+24.2%1.022%
2/16/2021Charles Schwab Investment Management Inc.375,499$21.48M0.0%+1.6%0.496%
2/13/2021American International Group Inc.34,909$2M0.0%-2.8%0.046%
2/12/2021Allstate Corp5,457$0.31M0.0%N/A0.007%
2/12/2021Penserra Capital Management LLC1,750$100K0.0%+170.9%0.002%
2/12/2021Federated Hermes Inc.117,230$6.71M0.0%N/A0.155%
2/12/2021Raymond James Financial Services Advisors Inc.23,286$1.33M0.0%+136.3%0.031%
2/12/2021The Manufacturers Life Insurance Company36,278$2.08M0.0%+2.7%0.048%
2/12/2021Credit Suisse AG90,570$5.18M0.0%-14.1%0.120%
2/12/2021Virtus ETF Advisers LLC5,668$0.32M0.1%-43.0%0.007%
2/11/2021Veritable L.P.3,543$0.20M0.0%N/A0.005%
2/11/2021Northern Trust Corp688,184$39.36M0.0%-2.5%0.909%
2/11/2021Baird Financial Group Inc.16,777$0.96M0.0%-23.0%0.022%
2/11/2021First Mercantile Trust Co.2,972$0.17M0.0%-22.1%0.004%
2/11/2021Barclays PLC88,630$5.07M0.0%-44.9%0.117%
2/11/2021Teacher Retirement System of Texas5,059$0.29M0.0%N/A0.007%
2/11/2021Oppenheimer & Co. Inc.4,267$0.24M0.0%-42.7%0.006%
2/10/2021Rhumbline Advisers74,511$4.26M0.0%+0.4%0.098%
2/10/2021Renaissance Technologies LLC216,313$12.37M0.0%N/A0.286%
2/10/2021Lisanti Capital Growth LLC134,945$7.72M1.1%N/A0.178%
2/9/2021CWA Asset Management Group LLC4,000$0.23M0.0%N/A0.005%
2/9/2021Bank of New York Mellon Corp254,207$14.54M0.0%+6.6%0.336%
2/9/2021Quantitative Systematic Strategies LLC14,169$0.81M0.1%+87.6%0.019%
2/9/2021ProShare Advisors LLC24,993$1.43M0.0%+27.9%0.033%
2/8/2021State Board of Administration of Florida Retirement System24,215$1.39M0.0%-2.8%0.032%
2/8/2021New York State Common Retirement Fund62,685$3.59M0.0%+14.0%0.083%
2/8/2021HC Advisors LLC5,718$0.33M0.2%N/A0.008%
2/8/2021FIL Ltd319,154$18.26M0.0%+146.8%0.397%
2/8/2021Russell Investments Group Ltd.41,019$2.35M0.0%-55.6%0.054%
2/6/2021Jennison Associates LLC2,772,420$158.58M0.1%-2.3%3.661%
2/5/2021BlackRock Inc.6,014,948$344.06M0.0%+0.6%7.942%
2/5/2021Aperio Group LLC4,113$0.24M0.0%N/A0.005%
2/5/2021Swiss National Bank128,200$7.33M0.0%-6.4%0.169%
2/4/2021Los Angeles Capital Management LLC8,805$0.50M0.0%+4.3%0.011%
2/4/2021GSA Capital Partners LLP6,215$0.36M0.1%-59.9%0.008%
2/4/2021State of Wisconsin Investment Board85,600$4.90M0.0%-11.1%0.113%
2/3/2021State of New Jersey Common Pension Fund D63,352$3.62M0.0%-23.9%0.084%
2/3/2021Bailard Inc.14,000$0.80M0.0%-17.2%0.018%
2/2/2021California Public Employees Retirement System139,978$8.01M0.0%+2.7%0.185%
2/1/2021Victory Capital Management Inc.1,909,977$109.25M0.1%-11.0%2.522%
1/30/2021Fiduciary Trust Co.573,071$32.78M0.7%+0.4%0.757%
1/28/2021Arizona State Retirement System16,444$0.94M0.0%-9.8%0.022%
1/25/2021Nisa Investment Advisors LLC2,950$0.17M0.0%+15.7%0.004%
1/25/2021Strs Ohio3,400$0.19M0.0%N/A0.004%
1/22/2021Candriam Luxembourg S.C.A.555,374$31.77M0.3%-51.7%0.733%
1/20/2021Pacer Advisors Inc.2,655$0.15M0.0%-21.7%0.004%
1/19/2021Rhenman & Partners Asset Management AB270,000$15.44M1.3%+20.0%0.356%
1/19/2021DNB Asset Management AS36,913$2.11M0.0%N/A0.049%
12/2/2020Teachers Retirement System of The State of Kentucky97,083$2.93M0.0%+5.9%0.128%
11/18/2020Great West Life Assurance Co. Can4,022$0.12M0.0%-63.4%0.005%
11/17/2020California State Teachers Retirement System90,923$2.74M0.0%+0.4%0.120%
11/16/2020Cubist Systematic Strategies LLC29,208$0.88M0.0%-20.5%0.039%
11/16/2020Point72 Asset Management L.P.446,936$13.48M0.1%+114.8%0.590%
11/16/2020AQR Capital Management LLC15,869$0.48M0.0%-41.0%0.021%
11/16/2020Squarepoint Ops LLC26,422$0.80M0.0%+15.9%0.035%
11/16/2020ExodusPoint Capital Management LP15,456$0.47M0.0%N/A0.020%
11/16/2020Weld Capital Management LLC11,360$0.34M0.1%N/A0.015%
11/13/2020Morgan Stanley39,799$1.20M0.0%-29.4%0.053%
11/13/2020Fiduciary Trust Co.570,591$17.22M0.4%-3.7%0.753%
11/13/2020ProShare Advisors LLC19,547$0.59M0.0%-3.4%0.026%
11/13/2020Charles Schwab Investment Management Inc.369,428$11.15M0.0%+2.0%0.488%
11/13/2020UBS Asset Management Americas Inc.66,855$2.02M0.0%+2.2%0.088%
11/13/2020Virtus ETF Advisers LLC9,947$0.30M0.2%-12.0%0.013%
11/13/2020Great West Life Assurance Co. Can244$29K0.0%-97.8%0.000%
11/13/2020AXA S.A.189,427$5.72M0.0%+11.0%0.250%
11/10/2020State Street Corp2,864,159$86.41M0.0%-2.8%3.782%
11/9/2020The Manufacturers Life Insurance Company35,338$1.07M0.0%-1.8%0.047%
11/9/2020Victory Capital Management Inc.2,145,462$64.73M0.1%+9.2%2.833%
11/9/2020Quantitative Systematic Strategies LLC7,554$0.23M0.0%N/A0.010%
11/9/2020Swiss National Bank136,900$4.13M0.0%+1.7%0.181%
11/9/2020State Board of Administration of Florida Retirement System24,915$0.75M0.0%+9.8%0.033%
11/6/2020BlackRock Inc.5,980,261$180.42M0.0%-3.2%7.896%
11/6/2020GSA Capital Partners LLP15,481$0.47M0.1%N/A0.020%
11/6/2020Aigen Investment Management LP10,308$0.31M0.0%N/A0.014%
11/5/2020California Public Employees Retirement System136,334$4.11M0.0%+2.6%0.180%
11/5/2020Alps Advisors Inc.96,415$2.91M0.0%-6.4%0.127%
11/4/2020American International Group Inc.35,911$1.08M0.0%-2.2%0.047%
11/4/2020Jennison Associates LLC2,837,786$85.62M0.1%+33.4%3.753%
11/4/2020Alps Advisors Inc.96,415$2.91M0.0%-6.4%0.128%
11/4/2020Smith Asset Management Group LP2,590$78K0.0%N/A0.003%
11/4/2020Raymond James Financial Services Advisors Inc.9,856$0.30M0.0%+20.2%0.013%
11/2/2020Private Advisor Group LLC70,525$2.30M0.0%-1.3%0.093%
Data available starting January 2016

See Full Table
Apellis Pharmaceuticals logo
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.
Read More

Today's Range

Now: $41.56
$41.29
$42.14

50 Day Range

MA: $45.01
$40.80
$51.18

52 Week Range

Now: $41.56
$25.49
$58.47

Volume

746,477 shs

Average Volume

643,630 shs

Market Capitalization

$3.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Apellis Pharmaceuticals?

Apellis Pharmaceuticals' top insider investors include:
  1. Cedric Francois (CEO)
  2. Alec Machiels (Director)
  3. A Sinclair Dunlop (Director)
  4. Federico Grossi (Insider)
  5. Nicole D Perry (VP)
  6. Timothy Eugene Sullivan (CFO)
  7. David O Watson (General Counsel)
  8. Pascal Deschatelets (COO)
  9. Pascal Deschatelets (Insider)
  10. Victoria L Brown (Insider)

Who are the major institutional investors of Apellis Pharmaceuticals?

Apellis Pharmaceuticals' top institutional shareholders include:
  1. Pacer Advisors Inc. — 0.00%

Which institutional investors are selling Apellis Pharmaceuticals stock?

Within the last quarter, APLS stock was sold by these institutional investors:
  1. Pacer Advisors Inc.
In the last year, company insiders that have sold Apellis Pharmaceuticals company stock include:
  1. Cedric Francois (CEO)
  2. Alec Machiels (Director)
  3. A Sinclair Dunlop (Director)
  4. Federico Grossi (Insider)
  5. Nicole D Perry (VP)
  6. Timothy Eugene Sullivan (CFO)
  7. David O Watson (General Counsel)
  8. Pascal Deschatelets (COO)
The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading
pixel